SCHEMBL7141574

SCHEMBL7141574

CSC1(SC)CCOc2ccc(/C(C)=C\c3ccc(C(=O)O)cc3)cc21

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 20/20 0.74
RARG P13631 20/20 0.74
RARA P10276 17/20 0.74
RXRA P19793 7/20 0.56
KDM4E B2RXH2 1/20 0.56
NPC1 O15118 1/20 0.56
CYP26A1 O43174 1/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
ALDH1A1 P00352 1/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
CYP1A2 P05177 1/20 0.56
POLB P06746 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
NFKB1 P19838 1/20 0.56
CYP2C19 P33261 1/20 0.56
THPO P40225 1/20 0.56
MTOR P42345 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8523001 0.86 RARB (0.55) RARBRARGRARARXRAKDM4E
SCHEMBL8101913 0.86 RARB (0.53) RARBRARGRARARXRACYP26A1
SCHEMBL7829468 0.85 RARB (1.00) RARBRARGRARARXRAKDM4E
SCHEMBL10551195 0.85 RARB (1.00) RARBRARGRARARXRAKDM4E
SCHEMBL7829470 0.85 RARB (1.00) RARBRARGRARARXRAKDM4E
SCHEMBL8459845 0.83 STAT3 (0.62) RARBRARGRARANPC1ALDH1A1
SCHEMBL4421853 0.81 KDM4E (0.50) RARBRARGRARARXRAKDM4E
SCHEMBL9817651 0.78 RARB (0.53) RARBRARGRARACYP26A1CYP3A4
SCHEMBL8460517 0.78 RARB (0.83) RARBRARGRARARXRAKDM4E
SCHEMBL8460515 0.78 RARB (0.83) RARBRARGRARARXRAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586460-B1 Administering heterocyclic ethers or sulfides to induce apoptosis, cell differentiation and as anticarcinogenic agents THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY 2003-07-01 US disclosed
EP-0907646-B1 DIHYDROBENZOPYRAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS UNIV VANDERBILT (US) 2003-05-21 EP disclosed
US-6110960-A FOR TREATING ARTHRITIS AND AS ANALGESIC THE PROCTER & GAMBLE COMPANY (US) 2000-08-29 US disclosed
EP-0907646-A1 DIHYDROBENZOPYRAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS THE PROCTER & GAMBLE COMPANY (US) 1999-04-14 EP disclosed
WO-1998007716-A2 HETEROAROTINOIDS-ANTICANCER AGENTS WITH RECEPTOR SPECIFICITY AND TGASE ACTIVITY THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) 1998-02-26 WO disclosed
WO-1997046548-A1 DIHYDROBENZOPYRAN AND RELATED COMPOUNDS USEFUL AS ANTI-INFLAMMATORY AGENTS THE PROCTER & GAMBLE COMPANY (US) 1997-12-11 WO disclosed
US-4826984-A Heteroarotinoid compounds as anticancer agents THE BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGE ACTING FOR AND ON BEHALF OF OKLAHOMA STATE UNIVERSITY (US) 1989-05-02 US disclosed